World's first generic to leading GnRH analogue with controlled release
Xbrane is pioneering high demand biosimilars.
OUTPERFORMING INDUSTRY STANDARDS BY DEVELOPING BIOSIMILARS WITH NEXT GENERATION TECHNOLOGY
Enabling access to critical medication for life critical diseases
Investors
Latest News
-
Xbrane Biopharma AB: Alessandro Sidoli och Saeid Esmaeilzadeh kommer inte att ställa upp för omval 2019
Read more >> -
Xbrane Biopharma AB: Alessandro Sidoli and Saeid Esmaeilzadeh decline re-election for 2019
Read more >> -
Xbrane Biopharma AB tidigarelägger bokslutskommunikén avseende räkenskapsåret 2018
Read more >> -
Xbrane Biopharma AB advances the release of the Year-end report for 2018
Read more >> -
Xbrane Biopharma AB informs about presentations where the company participates on February 19
Read more >>
X
